Group Prior Approvals
Applications for treatments excluded from tariff.
This page is in the process of being updated with accessible versions of the Group Prior Approvals. If you are unable to find the form you require, please email cpicb.prescribingpartnership@nhs.net to request a copy.
Adalimumab for Severe Localised Psoriasis in Adults - Local Agreement
TA103, 134, 146 Biologics for Plaque Psoriasis in Adults
TA177 Alitretinoin for the treatment of severe chronic hand eczema
TA350 Secukinumab for Plaque Psoriasis in Adults
TA475 Dimethyl fumerate for the treatment of moderate to severe plaque psoriasis in adults
TA511 Brodalumab in severe plaque psoriasis
TA534 Dupilumab for Atopic Dermatitis in Adults
TA574 Certolizumab for severe plaque psoriasis in adults
CamAPS FX for Adults and Children with Approved Funding for IPT - Local Agreement
Continuous Glucose Monitoring in Adults over 19 yrs - Local Agreement
Continuous Glucose Monitoring For Children and Young People Under 19yrs - Local Agreement
Medtronic EWIS 7-day Infusion Set - Local Agreement
Omnipod 5 Closed Loop System NICE TA151 and Local Agreement
TA151 Continuous Subcutaneous Insulin Infusion Therapy for Type I Diabetes Mellitus
TA863 Somatrogon for Growth Distrubance in Children and Adolescents Over 3yrs
Rituximab Biosimilar For Idiopathic Thrombocytopenic Purpura in Adults – Local Agreement
TA221 Romiplostim for Chronic Immune Thrombocytopenia in Adults
TA617 Lusutrombopag for severe thrombocytopenia prior to surgery in adults with liver disease
TA626 Avatrombopag for severe thrombocytopenia prior to surgery in adults with liver disease
TA853 Avatrombopag for Primary Chronic Immune Thrombocytopenia in Adults
Budesonide for Immunglobulin A Nephropathy (IgAN) in Adults
Liothyronine Sodium 20mcg Inj for thyrotoxic crisis - Local Agreement
TA358 Tolvaptan for treating autosomal dominant polycystic kidney disease in Adults
TA393 Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
TA394 Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia
MTG46 gammaCore for cluster headache accessible
TA659 Galcanezumab for Chronic Migraine in Adults
TA659 Galcanezumab for Episodic Migraine in Adults
TA758 Solriamfetol for treating excessive daytime sleepiness caused by narcolepsy
TA764 Fremanezumab for Chronic Migraine in Adults
TA764 Fremanezumab for Episodic Migraine in Adults
TA862 Erenumab for Chronic Migraine in Adults
TA862 Erenumab for Episodic Migraine in Adults
TA871 Eptinezumab for Chronic Migraine in Adults